Partner Insight

The story of Daily Command is not a product story. It is a story about what happens when an industry decides, at scale, that the way it has been working is no longer defensible.

By Harshit Jain, MD — Founder & Global CEO, Doceree

On an average Monday, a VP of Marketing running a two-billion-dollar pharma brand opens multiple systems to do the basic work of running their brand. A market research portal. An HCP targeting tool. A media-planning platform. A measurement dashboard. A CRM. A medical-legal-regulatory workflow. A competitive intelligence subscription. An agency project tracker. Underneath all of it, a stack of Excel files exported from each, reconciled by hand, often by a seasoned hand whose time is worth more than the reconciliation.

Strategy lives in one tool. Performance lives in another. The answer to what should we do today? lives in none of them.

The pharmaceutical brand team is the most strategically important and most poorly equipped function in life sciences. The industry has known this for two decades. It has not been fixed for two decades because the fix was not technically possible.

On May 7 in New York, 75 of the most senior operators in pharma marketing helped me unveil what becomes possible now that it is. The platform is called Daily Command. The trade press has covered the launch. Agency leaders have circulated the cohort list internally. Investors have asked the obvious question about market size. What none of that coverage has yet addressed is the question I want to take up here: not what Daily Command is, but why an industry agreed, in public and at the most senior level, to co-build it.

Eight years, one question

Eight years ago, I walked away from medicine — pulled by a single question: why does a physician prescribe what they prescribe? Two years later, the question had a name. Doceree.

I did not start Doceree because I wanted to build software. I started it because, after years of watching brilliant physicians make prescribing decisions inside a black box and brilliant marketers try to influence those decisions without seeing inside it, I had concluded that the most important unanswered question in commercial medicine was being routed around — by the entire pharmaceutical industry — every single day.

Three foundations had to be laid before that question could be answered at the level of a brand team’s daily work. A clinical-intent data layer that captures prescribing-decision signals at the point of care. Agentic AI capable of running brand-team workflows from end to end. And pharma-grade governance built into the substrate of the platform rather than bolted on. None of the three existed five years ago. Doceree spent the past six years building them. Daily Command is what becomes possible on the other side.

What “AI-native” actually means

I want to be careful with the phrase AI platform, because it has been emptied of meaning by overuse. Many companies currently describe themselves as AI platforms for pharma marketing. The vast majority are dashboards with a chat box in the corner, or a single workflow — usually content generation or HCP segmentation — wrapped in a GPT API call. That is not a platform. That is a feature.

When we describe Daily Command as AI-native, we mean something structural. Its modules are not workflows that have been augmented with AI features. They run brand-team work end to end — segment a market, brief a campaign, draft an MLR submission, reconcile a measurement discrepancy — and hand the operator a decision, not a dashboard.

The intelligence is the product, not a layer on top of the product.

This is the difference between AI that adds friction — one more tool to log into, one more interface to learn — and AI that removes it. The 75 Makers were not interested in building the former. They had enough of those.

Why agencies built it with us

I want to address something directly, because every agency leader reading this will be thinking it.

The Maker cohort includes senior leaders from Sanofi, Bristol Myers Squibb, Eli Lilly, Avalere Health, Deerfield, Havas Media, Omnicom Health Group, Real Chemistry, Ogilvy Health, and others. Five of the largest agency assets in healthcare chose to co-build this platform rather than wait to compete with it. That is, by itself, a piece of news the trade coverage has under-reported.

The reason they said yes is that Daily Command is not designed to replace the strategic work agencies do for their pharma clients. It is the surface where that work becomes visible to the brand team and connected to the data the brand team uses to act on it. Agencies that bring their proprietary IP, models, and frameworks into Daily Command — through the open marketplace we are launching alongside the July 14 industry release — make their work more valuable to the client, not less. The agencies inside the Maker cohort understood this before we built the marketplace. It is one of the reasons they said yes early.

The agencies that don’t will be writing briefs from yesterday’s Excel exports while the brand team is acting on today’s data.

Why we did not build it alone

There are two ways to build an AI platform for an industry. The first is to write the spec yourself, train the models, and show the result to customers. The second is to identify the people who run the function the platform is for and build it with them.

For Daily Command, the second approach was not a preference. It was a requirement.

Daily Command is not a tool that solves a single workflow. It is the environment in which the entire daily loop of a pharma brand team has to run — see, decide, activate, measure — without breaking. There are no vendors who have built that environment before, because no comparable platform exists in the industry. The only people in the world who know what it has to feel like, in detail, in friction, in failure cases, are the people who currently run that loop across 9 to 14 separate systems and have spent careers compensating for the seams.

So we asked 75 of them.

Who the 75 are, and why they said yes

The Makers, as we call them, are senior brand, marketing, commercial, medical, and agency leaders drawn from the largest manufacturers and the most influential agencies in the industry. They include leaders from Sanofi, Bristol Myers Squibb, Eli Lilly, Avalere Health, Deerfield, Havas Media, Omnicom Health Group, Real Chemistry, Ogilvy Health, and others.

Each was selected because they personally run the workflows Daily Command is designed to replace. Over the past quarter, they have contributed module specifications, stress-tested working AI agents in hundreds of hours of sessions and committed to bringing Daily Command into their organizations.

“Avalere Health has had decades of experience working closely with brand teams trying to make sophisticated, high-stakes commercial decisions across a dozen disconnected systems. I believe that Daily Command is the first platform to not just acknowledge this problem but also rebuild the workflow from the ground up. This partnership has a truly meaningful impact on our mission to make every patient possible. These are truly exciting times.”

— Amar Urhekar, CEO, Avalere Health

The reason these partners said yes is the reason that matters most for what this announcement actually means. They did not say yes because they like our company. They said yes because the cost — to them, to their teams, to the brands they run — of continuing to operate the way the industry has operated for two decades had become indefensible. The hours their teams spend reconciling data across systems are hours those teams are not spending on strategy. The decisions made on yesterday’s data are decisions less likely to be right than decisions made on today’s. The agency briefs written from Excel exports are briefs less likely to produce work that moves a market than briefs written from the same data the agency itself can see.

“Every category-defining software company in enterprise has been built on the same insight: own the surface where the work actually happens. In pharma marketing, and especially in full-service agencies like Deerfield, that surface has never existed. Daily Command is the most credible attempt I have seen at building it — grounded in real clinical data, designed by the operators who do the work, and architected as an open ecosystem rather than a closed AI stack.”

— Bill Veltre, Chief Media Officer, Deerfield

That is the diagnosis from inside the system. The 75 Makers are the industry, publicly deciding that this is no longer acceptable.

What happens next

Daily Command was officially unveiled on May 7, 2026, with its 75 Makers publicly named. In June, it enters closed beta with five flagship manufacturers and agency partners, including Avalere Health. The full industry release follows on July 14, alongside the announcement of Daily Command Marketplace launch partners. The list of named Makers, published with their consent, is at doceree.com/health-decode/makers

Eight years ago, I left a hospital ward because a question would not leave me alone. The answer is now in the hands of 75 of the people who are best qualified to use it.

What they do with it next is the part of the story I am most curious to watch.

About Doceree

Doceree is the world’s first AI-powered operating system for healthcare marketing, unifying the prescription journey from physician awareness to fill on a single platform. Its patented technology applies clinical, behavioural, and engagement signals to every HCP interaction in a privacy-compliant way. Founded in 2020, Doceree partners with the world’s leading healthcare and life sciences brands to move physicians from awareness to outcome — with measurable impact. Learn more at doceree.ai